Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

External validity of randomized controlled trials in COPD.

Travers J, Marsh S, Caldwell B, Williams M, Aldington S, Weatherall M, Shirtcliffe P, Beasley R.

Respir Med. 2007 Jun;101(6):1313-20. Epub 2006 Nov 17.

2.

External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?

Travers J, Marsh S, Williams M, Weatherall M, Caldwell B, Shirtcliffe P, Aldington S, Beasley R.

Thorax. 2007 Mar;62(3):219-23. Epub 2006 Nov 14.

3.

How have we been managing chronic obstructive pulmonary disease in Australia?

Matheson MC, Abeysena C, Raven JM, Skoric B, Johns DP, Abramson MJ, Walters EH.

Intern Med J. 2006 Feb;36(2):92-9.

PMID:
16472263
4.

Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.

Sobieraj DM, White CM, Coleman CI.

Clin Ther. 2008 Aug;30(8):1416-25. doi: 10.1016/j.clinthera.2008.08.004.

PMID:
18803985
5.
6.
7.

Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.

Bridevaux PO, Gerbase MW, Probst-Hensch NM, Schindler C, Gaspoz JM, Rochat T.

Thorax. 2008 Sep;63(9):768-74. doi: 10.1136/thx.2007.093724. Epub 2008 May 27.

PMID:
18505800
8.

The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea.

Kim SJ, Suk MH, Choi HM, Kimm KC, Jung KH, Lee SY, Lee SY, Kim JH, Shin C, Shim JJ, In KH, Kang KH, Yoo SH.

Int J Tuberc Lung Dis. 2006 Dec;10(12):1393-8.

PMID:
17167958
9.

What proportion of chronic obstructive pulmonary disease outpatients is eligible for inclusion in randomized clinical trials?

Scichilone N, Basile M, Battaglia S, Bellia V.

Respiration. 2014;87(1):11-7. doi: 10.1159/000355082. Epub 2013 Nov 20.

10.

Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.

Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Zhou Y, Liu S, Wang X, Wang D, Lu J, Zheng J, Ran P.

Am J Respir Crit Care Med. 2007 Oct 15;176(8):753-60. Epub 2007 Jun 15. Erratum in: Am J Respir Crit Care Med. 2007 Dec 1;176(11):1169.

PMID:
17575095
11.

Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.

Wilt TJ, Niewoehner D, MacDonald R, Kane RL.

Ann Intern Med. 2007 Nov 6;147(9):639-53. Review.

PMID:
17975187
12.

Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.

Kurashima K, Hara K, Yoneda K, Kanauchi T, Kagiyama N, Tokunaga D, Takayanagi N, Ubukata M, Sugita Y.

Respirology. 2009 Mar;14(2):239-44. doi: 10.1111/j.1440-1843.2008.01452.x. Epub 2008 Dec 11.

PMID:
19210650
13.

COPD screening efforts in primary care: what is the yield?

Tinkelman DG, Price D, Nordyke RJ, Halbert RJ.

Prim Care Respir J. 2007 Feb;16(1):41-8.

14.

The 2007 GOLD Guidelines: a comprehensive care framework.

Gold PM.

Respir Care. 2009 Aug;54(8):1040-9. Review. Erratum in: Respir Care. 2009 Nov;54(11):1501.

15.

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease.

Donohue JF, Jones PW.

Int J Chron Obstruct Pulmon Dis. 2011 Jan 7;6:35-45. doi: 10.2147/COPD.S14680. Review.

16.

Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.

Lindberg A, Larsson LG, Rönmark E, Jonsson AC, Larsson K, Lundbäck B.

COPD. 2007 Mar;4(1):5-13.

PMID:
17364672
17.

Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease.

Miravitlles M, Price D, Rabe KF, Schmidt H, Metzdorf N, Celli B.

Int J Chron Obstruct Pulmon Dis. 2015 Mar 16;10:549-64. doi: 10.2147/COPD.S71913. eCollection 2015. Review.

18.

Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.

Chen AM, Bollmeier SG, Finnegan PM.

Ann Pharmacother. 2008 Dec;42(12):1832-42. doi: 10.1345/aph.1L250. Epub 2008 Oct 28. Review.

PMID:
18957624
19.

Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.

Donohue JF, Hanania NA, Ciubotaru RL, Noe L, Pasta DJ, Schaefer K, Claus R, Andrews WT, Roach J.

Clin Ther. 2008;30 Spec No:989-1002. doi: 10.1016/j.clinthera.2008.06.010.

PMID:
18640474
20.

Worldwide guidelines for chronic obstructive pulmonary disease: a comparison of diagnosis and treatment recommendations.

Iqbal A, Schloss S, George D, Isonaka S.

Respirology. 2002 Sep;7(3):233-9. Review.

PMID:
12153689

Supplemental Content

Support Center